ASTRO - American Society for Radiation Oncology - 2013 Annual Meeting

September 22 - 25, 2013     Atlanta, Georgia

September 22, 2013

September 22 - 25, 2013

Atlanta, Georgia

 

http://astro2013.abstractsnet.com/aposter.wcs?entryid=010001 

Poster & Discussion by Dr. Ruby Meredith, principal investigator for AREVA Med's Phase 1 clinical trial with Pb212-TCMC-Trastuzumab:

Early Results of Phase 1 Trial with New Anti-HER-2 Radionuclide Conjugate

Contact

For more information about AREVA Med, please contact:
Alison Tise
Tel.: + 1 (301) 841-1673